Bank of New York Mellon Corp
BankPosition in GLUE — Monte Rosa Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in GLUE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$5,385,007
+$2,017,908 QoQ
Shares Held
222,521
+8.7% QoQ
Ownership
0.261%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 193 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. GLUE ranks #95 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in GLUE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,385,007 | 222,521 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $3,367,099 | 204,687 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,717,405 | 173,304 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,384,171 | 186,798 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $790,796 | 175,343 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $761,630 | 164,145 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,181,964 | 170,312 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $883,472 | 166,693 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $410,890 | 109,864 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $662,833 | 94,019 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $567,915 | 100,516 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $450,522 | 94,055 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $644,515 | 94,090 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $689,063 | 88,455 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $679,511 | 89,292 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $715,952 | 87,632 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $678,910 | 70,208 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,041,951 | 74,319 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $653,010 | 31,979 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $620,630 | 27,856 | Shares | Defined | 2021-11-18 | |
| No filing history on record for this holder in this stock. | ||||||